No Image Available

Nirmatrelvir + Ritonavir

Form: Tablets

Strength: 150mg, 100mg

Reference Brands:

Category: Anti Covid Medicines

The US Food and Drug Administration (FDA) has authorized emergency use of nirmatrelvir in combination with another medicine called ritonavir for the treatment of mild-to-moderate COVID-19 in adults and people 12 years of age and older (weighing at least 40 kg or 88 lbs) testing positive for COVID-19, and who are at high risk for progression to severe COVID-19, including hospitalization or death.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Baricitinib

Strength: 2 mg, 4 mg

Form: Tablet

Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)

View Details Get Enquiry
Nirmatrelvir + Ritonavir

Strength: Nirmatrelvir(150 mg) + Ritonavir(100 mg)

Form: Tablet

Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)

View Details Get Enquiry
Tocilizumab

Strength: IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)

Form: IV injection, SQ Injection

Reference Brands: Actemra®(US); RoActemra®(EU)

View Details Get Enquiry
Molnupiravir

Strength: 200 mg

Form: Oral capsule

Reference Brands: Lagevrio®(Us & EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.